Penrose TherapeuTx

Penrose TherapeuTx is a U.S.-based pharmaceutical company dedicated to developing innovative small-molecule therapies for the treatment of advanced cancers. Penrose has developed a proprietary, chemistry-driven research platform focused on the metabolism and signaling of cancer mitochondria. Preclinical studies have shown that the company's lead candidate drug exhibits a strong in vivo efficacy signal, with an Investigational New Drug (IND) application expected to be filed in the first quarter of 2021 to enable the initiation of clinical research.